Corporate News 24-Mar-23
USFDA inspects Alembic Pharmaceuticals' Karkhadi unit
Alembic Pharmaceuticals announced that the United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' Injectable and Ophthalmic Facility (F-3) located at Karkhadi from 16 March 2023 to 24 March 2023. The USFDA issued a Form 483 with 2 minor procedural observations.
Previous News
Alembic Pharma gets USFDA nod for osteoarthritis drug
( Hot Pursuit - 01-Dec-22 11:44 )
Alembic Pharma records 48% growth in Q3 PAT
( Hot Pursuit - 05-Feb-24 16:29 )
Alembic receives USFDA approval for Fesoterodine Fumarate ER Tablets
( Corporate News - 06-Jan-23 11:03 )
Alembic Pharma gets USFDA final approval for Prazosin Hydrochloride capsules
( Hot Pursuit - 08-Mar-23 09:19 )
Alembic Pharmaceuticals receives USFDA tentative approval for Ribociclib Tablets
( Corporate News - 01-Apr-24 11:51 )
Volumes spurt at Blue Star Ltd counter
( Hot Pursuit - 20-Sep-23 14:30 )
Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
( Corporate News - 07-Apr-22 13:53 )
Alembic receives USFDA approval for Diclofenac Sodium Topical Solution
( Corporate News - 01-Dec-22 11:17 )
Alembic Pharma's Panelav facility gets EIR from USFDA
( Hot Pursuit - 09-Dec-22 14:23 )
USFDA issues EIR for Alembic's Panelav oncology injectable formulation unit
( Corporate News - 09-Dec-22 13:39 )
Alembic Pharma gets USFDA nod for Nifedipine tablets
( Hot Pursuit - 21-Nov-22 11:14 )
Other Stories
Go Fashion (India) AGM scheduled
29-Jun-24 17:32
TARC to convene EGM
29-Jun-24 17:32
Shrem InvIT AGM scheduled
29-Jun-24 17:32
Dabur India schedules AGM
29-Jun-24 17:32
Brookfield India Real Estate Trust schedules AGM
29-Jun-24 17:31
Bank of Baroda to table results
29-Jun-24 17:31
V-Mart Retail AGM scheduled
29-Jun-24 17:31
Oriental Infra Trust schedules AGM
29-Jun-24 17:31
SAR Televenture to hold board meeting
29-Jun-24 17:31
Panasonic Energy India Company to hold AGM
29-Jun-24 17:30
Back
Top
